Advertisement

Topics

Ipsen Biopharmaceuticals Inc. Company Profile

01:40 EST 15th December 2018 | BioPortfolio


News Articles [275 Associated News Articles listed on BioPortfolio]

With New HQ, Ipsen to Rapidly Expand North American Presence

With a patient-centric focus, Ipsen Biopharmaceuticals is on a mission to improve patients’ lives, leveraging its global reach and placing a strategic focus on external innovation.

Ipsen Biopharma's Cabometyx tablets to treat adults with advanced RCC receives Canadian approval

Exelixis, Inc has announced that its partner Ipsen Biopharmaceuticals Canada Inc. received approval from Health Canada of Cabometyx (cabozantinib) tablets for the treatment of adults with advanced ren...

Ipsen to present new data from its oncology portfolio at the 2018 European Society for Medical ...

For further information :IpsenMediaIan Weatherhead, +44 (0) 1753 627733Vice President, Corporate External Communicationsian.weatherhead@ipsen.comorFanny Allaire, +33 (0) 1 58 33 ...

Ipsen receives approval from Health Canada for CABOMETYX tablets for treating renal cell carcinoma

Exelixis, Inc. today announced that its partner Ipsen Biopharmaceuticals Canada Inc. received approval from Health Canada of CABOMETYX® tablets for the treatment of adults with advanced renal cell ca...

Ipsen appoints new general manager for the UK & Ireland

The French pharma company appointed a new general manager for its UK and Ireland office, Asad Mohsin Ali, who brings two decades of commercial experience and a bold vision for Ipsen’s global footpri...

Lexicon Pharmaceuticals and Ipsen Biopharmaceuticals Canada Inc. Announce Health Canada Approval of XERMELO® (Telotristat Ethyl) for the Treatment of Refractory Carcinoid Syndrome Diarrhea in Combination With Somatostatin Analog Therapy

Approval Enables Availability of First-in-Class Oral Tryptophan Hydroxylase Inhibitor that Sustains Improvement of Carcinoid Syndrome Diarrhea in Adults Inadequately Controlled by Somatostatin Analog...

Ipsen and BioLabs to open new Innovation Center in Cambridge (U.S. ...

Ipsen Innovation Center – BioLabs to be located in Ipsen’s new and third global hub in the heart of Cambridge, Massachusetts Read more...

Ipsen And BioLabs To Open New Innovation Center To Foster Development Of New Therapies

NewsThe shared laboratory space, called the ‘Ipsen Innovation Center - BioLabs’ (IPSEN-ICB) will be a fully equipped 15,000 square-feet combined office and laboratory facility dedicated to support...

Drugs and Medications [2 Associated Drugs and Medications listed on BioPortfolio]

Thrombin human [Ethicon, Inc]

These highlights do not include all the information needed to use EVITHROM safely and effectively. See full prescribing information for EVITHROM.EVITHROM, Thrombin, Topical (Human)For Topical Use Only...

Somatuline depot [Beaufour Ipsen Pharma SAS]

Somatuline Depot (lanreotide) Injection

PubMed Articles [36 Associated PubMed Articles listed on BioPortfolio]

Acknowledgement to Referees.

Characterisation of protein aggregation with the Smoluchowski coagulation approach for use in biopharmaceuticals.

Protein aggregation is a field of increasing importance in the biopharmaceutical industry. Aggregated particles decrease the effectiveness of the drug and are associated with other risks, such as incr...

Harnessing the power of an expanded genetic code toward next-generation biopharmaceuticals.

Synthetic biology has been revolutionizing the biopharmaceutical industry from drug discovery, clinical development to the manufacturing of biopharmaceuticals. As one of its most promising areas, gene...

Selective N-terminal acylation of peptides and proteins with a Gly-His tag sequence.

Methods for site-selective chemistry on proteins are in high demand for the synthesis of chemically modified biopharmaceuticals, as well as for applications in chemical biology, biosensors and more. I...

Surface-induced crystallization of pharmaceuticals and biopharmaceuticals: a review.

Despite crystallization wide occurrence in pharmaceutical industry, deep understanding and fine control of the process remain tricky issues. Nevertheless, the successful manufacturing of finished phar...

Clinical Trials [7 Associated Clinical Trials listed on BioPortfolio]

Nicotine Vaccination and Nicotinic Receptor Occupancy

This is a molecular imaging research study designed to examine how much nicotine gets into the brain before and after vaccination with NicVAX, a nicotine vaccine developed by Nabi Biopharm...

Administration of GnRH Antagonist to Oocyte Donation Recipients

This prospective and randomized study was performed to evaluate whether the replacement of GnRH agonist by a GnRH antagonist in oocyte donation recipients during endometrial preparation h...

A Phase III Clinical Trial of a Haemophilus Influenzae Type b (Hib) Conjugate Vaccine

Haemophilus influenza type b (Hib) remains a serious global health threat associated with high mortality and morbidity in young children. In China, The overall impact of Hib-related infect...

Flexible GnRH Antagonist vs Flare up GnRH Agonist Protocol in Poor Responders

The purpose of this study is to compare ovulation induction using a flexible GnRH antagonist protocol and flare up GnRH agonist protocol in IVF patients with poor response to ovarian stimu...

Comparison Between GnRH Agonist and GnRH Antagonist Protocols of Ovarian Stimulation in PCOS Patients

The purpose of this study is to compare pregnancy rates and the occurrence of OHSS in PCOS patients who were treated with GnRH agonist and GnRH antagonist protocols ovarian stimulation dur...

Companies [200 Associated Companies listed on BioPortfolio]

Ipsen Biopharmaceuticals Inc.

Ipsen N.A.

Ipsen is a global specialty-driven pharmaceutical company with total sales exceeding €1.2 billion in 2013. Ipsen’s ambition is to become a leader in specialty healthcare...

Ipsen S.A.

Ipsen is a global biopharmaceutical group, with sales exceeding 1 billion euros in 2009. The Group has total worldwide staff of more than 4,400 employees, of which nearly 900 cont...

The Fondation IPSEN

Established in 1983 under the aegis of the Fondation de France, the ambition of the Fondation IPSEN is to initiate a reflection about the major scientific issues of the forthcomin...

Ipsen

Ipsen is a global biopharmaceutical group with total sales in excess of 1 billion euros in 2009, and total worldwide staff of more than 4,400. Its strategy is based on fast growin...

More Information about "Ipsen Biopharmaceuticals Inc." on BioPortfolio

We have published hundreds of Ipsen Biopharmaceuticals Inc. news stories on BioPortfolio along with dozens of Ipsen Biopharmaceuticals Inc. Clinical Trials and PubMed Articles about Ipsen Biopharmaceuticals Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Ipsen Biopharmaceuticals Inc. Companies in our database. You can also find out about relevant Ipsen Biopharmaceuticals Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record